Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a RCSD1::ABL2 fusion gene

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)123-127
Number of pages5
JournalLeukemia and Lymphoma
Volume65
Issue number1
DOIs
StatePublished - 2024
Externally publishedYes

Keywords

  • Acute lymphoblastic leukemia
  • Philadelphia chromosome-like
  • RCSD1::ABL2 fusion gene
  • targetable kinase fusions
  • tyrosine kinase inhibitors

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this